Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

NSCLC 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 71pembrolizumab 70Pemetrexed 62Cisplatin 46Nivolumab 28Paclitaxel 27durvalumab 26Specimen Handling 25osimertinib 23Docetaxel 23Magnetic Resonance Spectroscopy 21Gemcitabine 17Cetuximab 15130-nm albumin-bound paclitaxel 15atezolizumab 14amivantamab 14Radiotherapy 12Radiosurgery 12lazertinib 11Ipilimumab 9Bevacizumab 9cemiplimab 8Taxes 8Drug Therapy 8alectinib 7Ramucirumab 7Observation 7Radiation 6Leucovorin 5Immunoglobulin G 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Anterior Temporal Lobectomy × 30 days × Clear all
NCT03237377 2026-05-27

Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
9 enrolled 14 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡